CNO Stock Forecast 2025-2026
Distance to CNO Price Targets
CNO Price Momentum
10 Quality Stocks Worth Considering Now
Researching CNO Financial (CNO) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on CNO and similar high-potential opportunities.
Latest CNO Stock Price Targets & Analyst Predictions
Based on our analysis of 12 Wall Street analysts, CNO has a neutral consensus with a median price target of $43.00 (ranging from $40.00 to $49.00). The overall analyst rating is Hold (5.7/10). Currently trading at $39.76, the median forecast implies a 8.1% upside. This outlook is supported by 1 Buy, 4 Hold, and 1 Sell ratings.
The most optimistic forecast comes from John Barnidge at Piper Sandler, projecting a 23.2% upside. Conversely, the most conservative target is provided by Scott Heleniak at RBC Capital, suggesting a 0.6% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CNO Analyst Ratings
CNO Price Target Range
Latest CNO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CNO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 2, 2025 | Piper Sandler | John Barnidge | Overweight | Maintains | $49.00 |
| Feb 12, 2025 | Keefe, Bruyette & Woods | Ryan Krueger | Market Perform | Maintains | $44.00 |
| Feb 10, 2025 | RBC Capital | Scott Heleniak | Outperform | Maintains | $45.00 |
| Feb 10, 2025 | Piper Sandler | John Barnidge | Overweight | Reiterates | $46.00 |
| Jan 23, 2025 | BMO Capital | Jack Matten | Market Perform | Initiates | $38.00 |
| Dec 18, 2024 | Piper Sandler | John Barnidge | Overweight | Maintains | $44.00 |
| Dec 10, 2024 | Jefferies | Suneet Kamath | Hold | Maintains | $41.00 |
| Nov 4, 2024 | RBC Capital | Scott Heleniak | Outperform | Maintains | $40.00 |
| Oct 2, 2024 | Piper Sandler | John Barnidge | Overweight | Maintains | $38.00 |
| Sep 13, 2024 | Piper Sandler | John Barnidge | Overweight | Reiterates | $37.00 |
| Jul 31, 2024 | Evercore ISI Group | Thomas Gallagher | Underperform | Maintains | $29.00 |
| Jul 31, 2024 | RBC Capital | Scott Heleniak | Outperform | Maintains | $38.00 |
| Jul 8, 2024 | Keefe, Bruyette & Woods | Ryan Krueger | Market Perform | Maintains | $31.00 |
| Jun 28, 2024 | Piper Sandler | John Barnidge | Overweight | Maintains | $31.00 |
| Apr 16, 2024 | Piper Sandler | John Barnidge | Overweight | Upgrade | $29.00 |
| Feb 28, 2024 | Evercore ISI Group | Thomas Gallagher | Underperform | Maintains | $27.00 |
| Feb 8, 2024 | RBC Capital | Scott Heleniak | Outperform | Maintains | $30.00 |
| Jan 4, 2024 | Evercore ISI Group | Thomas Gallagher | Underperform | Downgrade | $26.00 |
| Nov 8, 2023 | RBC Capital | Scott Heleniak | Outperform | Maintains | $28.00 |
| Sep 14, 2023 | Jefferies | Suneet Kamath | Hold | Maintains | $24.00 |
CNO Financial Group Inc. (CNO) Competitors
The following stocks are similar to CNO Financial based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
CNO Financial Group Inc. (CNO) Financial Data
CNO Financial Group Inc. has a market capitalization of $3.93B with a P/E ratio of 10.5x. The company generates $4.45B in trailing twelve-month revenue with a 9.1% profit margin.
Revenue growth is -6.3% quarter-over-quarter, while maintaining an operating margin of +24.8% and return on equity of +17.1%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
CNO Financial Group Inc. (CNO) Business Model
About CNO Financial Group Inc.
Provides insurance products for middle-income Americans.
CNO Financial Group operates as a holding company for various insurance-oriented subsidiaries, generating revenue through the sale of life insurance, annuities, and supplemental health insurance. The company targets middle-income Americans, particularly those nearing retirement, and utilizes multiple distribution channels including career agents and direct marketing to reach its customers effectively.
Founded in 1979 and based in Carmel, Indiana, CNO Financial emphasizes customer service and community involvement. The company plays a significant role in the U.S. insurance industry by helping clients manage financial risks associated with retirement and healthcare, contributing to broader economic stability.
Company Information
Sector
Financial Services
Industry
Insurance - Life
Employees
3,500
CEO
Mr. Gary Chandru Bhojwani
Country
United States
IPO Year
2003
Website
www.cnoinc.comCNO Financial Group Inc. (CNO) Latest News & Analysis
The Hartford to Release Q1 Earnings: Key Estimates to Watch
HIG's Q1 results are expected to gain on new business growth and prudent rate hikes in the Business Insurance segment, partly offset by increased marketing expenses.
CNO Financial (CNO) Reports Next Week: Wall Street Expects Earnings Growth
CNO (CNO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Latest News
CNO is expected to potentially exceed earnings expectations in its upcoming report, driven by favorable key factors.
CNO's potential earnings beat could boost investor confidence and share prices, signaling strong financial performance and positive market sentiment.
CNO Financial Group, Inc. (NYSE: CNO) will report its Q1 2025 results on April 28, 2025, after market close.
CNO Financial's upcoming quarterly earnings report could impact its stock price and investor sentiment, providing insights into financial health and growth prospects.
CNO Financial: Hidden Gem
13 days agoCNO Financial Group has delivered a 278% 5-year return, outperforming the S&P 500, with strong 2024 growth, improved margins, and a robust capital structure, ensuring stability and growth potential.
CNO Financial's strong performance and solid capital structure indicate robust financial health, promising growth potential, and resilience, making it an attractive option for investors.
CNO has a strong earnings surprise history and favorable conditions suggesting a probable earnings beat in its upcoming quarterly report.
CNO's strong earnings surprise history and favorable indicators suggest potential for exceeding expectations in the upcoming report, impacting stock performance positively.
CNO Financial (CNO) and CME Group (CME) have shown performance metrics relative to their sector for the year to date. Specific details on performance were not provided.
Performance comparisons reveal relative strength or weakness of CNO Financial and CME Group against their sector, influencing investment decisions and potential market trends.
Zacks emphasizes its Rank system based on earnings estimates and revisions to identify strong stocks, while also monitoring value, growth, and momentum trends.
The emphasis on earnings estimates and revisions indicates potential stock performance, guiding investors to identify high-quality stocks and capitalize on market trends.
Frequently Asked Questions About CNO Stock
What is CNO Financial Group Inc.'s (CNO) stock forecast for 2025?
Based on our analysis of 12 Wall Street analysts, CNO Financial Group Inc. (CNO) has a median price target of $43.00. The highest price target is $49.00 and the lowest is $40.00.
Is CNO stock a good investment in 2025?
According to current analyst ratings, CNO has 1 Buy ratings, 4 Hold ratings, and 1 Sell ratings. The stock is currently trading at $39.76. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CNO stock?
Wall Street analysts predict CNO stock could reach $43.00 in the next 12 months. This represents a 8.1% increase from the current price of $39.76. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is CNO Financial Group Inc.'s business model?
CNO Financial Group operates as a holding company for various insurance-oriented subsidiaries, generating revenue through the sale of life insurance, annuities, and supplemental health insurance. The company targets middle-income Americans, particularly those nearing retirement, and utilizes multiple distribution channels including career agents and direct marketing to reach its customers effectively.
What is the highest forecasted price for CNO CNO Financial Group Inc.?
The highest price target for CNO is $49.00 from John Barnidge at Piper Sandler, which represents a 23.2% increase from the current price of $39.76.
What is the lowest forecasted price for CNO CNO Financial Group Inc.?
The lowest price target for CNO is $40.00 from Scott Heleniak at RBC Capital, which represents a 0.6% increase from the current price of $39.76.
What is the overall CNO consensus from analysts for CNO Financial Group Inc.?
The overall analyst consensus for CNO is neutral. Out of 12 Wall Street analysts, 1 rate it as Buy, 4 as Hold, and 1 as Sell, with a median price target of $43.00.
How accurate are CNO stock price projections?
Stock price projections, including those for CNO Financial Group Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.